Atropine Ophthalmic
64 interactions 238 cited referencesOphthalmic atropine is used before eye examinations to dilate (open) the pupil, the black part of the eye through which you see. It is also used to relieve pain caused by swelling and inflammation of the eye. Read the full Atropine Ophthalmic drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Atropine Ophthalmic Phenelzine Nardil Potential to cause hypertensive crisis Details Atropine Ophthalmic Procarbazine Potential to cause hypertensive crisis Details Atropine Ophthalmic Promethazine Phenadoz Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Atropine Ophthalmic Quetiapine Seroquel An increased risk of anticholinergic side effects, including intestinal obstruction Details Atropine Ophthalmic Rasagiline Azilect Potential to cause hypertensive crisis Details Atropine Ophthalmic Revefenacin Yupelri Increased risk of anticholinergic side effects Details Atropine Ophthalmic Safinamide Xadago Potential to cause hypertensive crisis Details Atropine Ophthalmic Scopolamine Pamine Increased or potentiated scopolamine effects, an increased risk of CNS adverse reactions and an increased risk of intestinal obstr... Details Atropine Ophthalmic Secretin Human Chirhostim False positive stimulation test results with secretin human Details Atropine Ophthalmic Selegiline Anipryl Potential to cause hypertensive crisis Details Atropine Ophthalmic Sofpironium An increased risk of hyperpyrexia and heat stroke due to decreased sweating Details Atropine Ophthalmic Sufentanil Dsuvia Increased risk of urinary retention and/or severe constipation leading to paralytic ileus Details Atropine Ophthalmic Taletrectinib Ibtrozi Increased risk of QT interval prolongation and torsade de pointes Details Atropine Ophthalmic Tapentadol Nucynta An increased risk of paralytic ileus Details Atropine Ophthalmic Tiotropium An increased risk of anticholinergic side effects Details Atropine Ophthalmic Tramadol ConZip Increased risk of urinary retention and/or severe constipation leading to paralytic ileus and an increased risk of seizure Details Atropine Ophthalmic Tranylcypromine Parnate Potential to cause hypertensive crisis DetailsModerate
Atropine Ophthalmic Arbutamine Unreliable arbutamine test results Details Atropine Ophthalmic Cobicistat Tybost Increased antiarrhythmic exposure Details Atropine Ophthalmic Trospium An increased risk of anticholinergic adverse reactions (eg, dry mouth, constipation) Details Atropine Ophthalmic Xanomeline An increased risk of anticholinergic adverse reactions (eg, dry mouth, constipation) DetailsMinor
Atropine Ophthalmic Belladonna Excessive anticholinergic activity (severe dry mouth, constipation, decreased urination, excessive sedation, blurred vision) Details Atropine Ophthalmic Belladonna Alkaloids Excessive anticholinergic activity (severe dry mouth, constipation, decreased urination, excessive sedation, blurred vision) Details Atropine Ophthalmic Cisapride Propulsid® Loss of cisapride efficacy DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist